NCT02876432

Brief Summary

Activation of the sympathetic nervous system attenuates inflammation via catecholamines, recent advances in electroacupuncture allow activating critical neuronal networks with the release of catecholamines the aim of this research was to evaluate de effect of electroacupuncture in the activation of sympathetic nervous system and the control of low back pain in athletes

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable low-back-pain

Timeline
Completed

Started Oct 2016

Shorter than P25 for not_applicable low-back-pain

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2016

Completed
7 days until next milestone

First Posted

Study publicly available on registry

August 23, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2017

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2017

Completed
Last Updated

August 1, 2018

Status Verified

July 1, 2018

Enrollment Period

3 months

First QC Date

August 16, 2016

Last Update Submit

July 30, 2018

Conditions

Outcome Measures

Primary Outcomes (2)

  • Visual analogue scale

    in a horizontal line, 100 mm in length, anchored by word descriptors at each end. The patient marks on the line the point that they feel represents their perception of their current state. The VAS score is determined by measuring in millimetres from the left hand end of the line to the point that the patient marks

    before Electroacupuncture Time "0"

  • Levels of catecholamines in serum

    Blood was collected into chilled heparin tubes serum catecholamines were determined by ELISA (Rocky Mountain Diagnostics, Colorado Springs, CO)

    five minutes before Electroacupuncture

Secondary Outcomes (2)

  • Levels of catecholamines in serum

    five minutes after Electroacupuncture

  • Visual analogue scale

    Five days after Electroacupuncture

Study Arms (3)

Device: Electroacupuncture

EXPERIMENTAL

The acupuncture points selected were ST36, BL25, GB30, BL40, GB34 the needles were inserted into acupoints and the depth of needle insertion depended of the acupoints selected to achieve Deqi sensation, which is characterized as a numb, heavy, sore and/or distending sensation. Electrical stimulation was delivered at 4 Hz. The stimulator (ITO EST-160) was then switched on, and the intensity was gradually increased to reach a strong but comfortable level the sensation of EA which is characterized for numbness, tingling and a light muscle cramp. For 15 minutes

Device: ElectroacupunctureOther: Sham electroacupuncture

Device: Sham Electroacupuncture

SHAM COMPARATOR

In sham electroacupuncture (Sham) the investigators use 1.0 cm outside point of the real electroacupuncture, the depth of needle insertion was superficial to avoid Deqi sensation, the cables wasn't connected to the electro stimulator and was then switched on for 15 minutes. The participants were threaded separately to avoid sharing experiences about the electroacupuncture sessions

Device: ElectroacupunctureOther: Sham electroacupuncture

Drug: Diclofenac sodium

ACTIVE COMPARATOR

100 mg Diclofenac sodium was administrated orally every 12 hours for 5 days.

Drug: Diclofenac sodium

Interventions

The acupuncture points selected were ST36, BL25, GB30, BL40, GB34 the needles were inserted into acupoints and the depth of needle insertion depended of the acupoints selected to achieve Deqi sensation, which is characterized as a numb, heavy, sore and/or distending sensation. Electrical stimulation was delivered at 4 Hz. The stimulator (ITO EST-160) was then switched on, and the intensity was gradually increased to reach a strong but comfortable level the sensation of EA which is characterized for numbness, tingling and a light muscle cramp. For 15 minutes

Device: ElectroacupunctureDevice: Sham Electroacupuncture

100 mg Diclofenac sodium was administrated orally every 12 hours for 5 days.

Drug: Diclofenac sodium

The investigators use 1.0 cm outside point of the real electroacupuncture, the depth of needle insertion was superficial to avoid Deqi sensation, the cables wasn't connected to the electro stimulator and was then switched on for 15 minutes. The participants were threaded separately to avoid sharing experiences about the electroacupuncture sessions

Device: ElectroacupunctureDevice: Sham Electroacupuncture

Eligibility Criteria

Age18 Years - 30 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • (Controls)
  • Healthy
  • Non Smokers
  • Athletes
  • (Cases)
  • Acute Low Back Pain (less than 1 month)
  • Athletes
  • Non Smokers

You may not qualify if:

  • Sciatic Pain
  • Smokers
  • Chronic Low Back Pain

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Low Back Pain

Interventions

ElectroacupunctureDiclofenac

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesiaPhenylacetatesAcids, CarbocyclicCarboxylic AcidsOrganic Chemicals

Study Officials

  • Lourdes Arriaga Pizano, MD PhD

    IMSS

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Time Professor Researcher

Study Record Dates

First Submitted

August 16, 2016

First Posted

August 23, 2016

Study Start

October 1, 2016

Primary Completion

January 1, 2017

Study Completion

February 1, 2017

Last Updated

August 1, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share